Pomerantz Law Firm Initiates Class Action Against Dow Inc. Over Securities Violations
On September 23, 2025, Pomerantz LLP announced that it has initiated a class action lawsuit against Dow Inc. and certain of its executives. The lawsuit was filed in the United States District Court for the Eastern District of Michigan and is identified as case number 25-cv-12744. This legal action is relevant for all individuals and entities that acquired Dow securities from January 30, 2025, to July 23, 2025.
In essence, the plaintiffs seek to recover damages resulting from what they claim are violations of federal securities laws by units of Dow's management. The litigation focuses on disclosures made by the company during this class period, which supposedly misrepresented the company's financial stability and ability to maintain its acclaimed dividend payments.
The components of the class action revolve around Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, alongside Rule 10b-5, which targets fraud in the securities realm. Investors who purchased Dow securities during the affected time frame are urged to come forward by the October 28, 2025, deadline to be considered for the role of Lead Plaintiff.
Notably, Dow Inc. operates as a significant player in the materials science sector, providing solutions across various industries, including packaging, infrastructure, and consumer applications. The company traditionally emphasized its impressive dividends to attract and retain investors. Jim Fitterling, Dow's CEO, has previously touted the dividend as a cornerstone of the company's investment appeal, mentioning that a large section of their investor base highly relies on it.
However, Dow's position appears tenuous as recent market fluctuations and uncertainties linked to tariffs have begun to affect its operations seriously. Despite management claiming that the firm was well-prepared to navigate these macroeconomic challenges, numerous indicators from Dow's operational performance suggested the contrary.
Over the duration of the class period, defendants allegedly issued false and misleading information about Dow's financial health and growth potential. They purportedly downplayed the adverse effects of economic downturns and fluctuating global sales on the company's bottom line. The supposed strength of Dow's operations and its ability to sustain its dividend were presented in an overly optimistic light, which may not have reflected the actual situation.
In June 2025, BMO Capital notably downgraded Dow's stock from
In essence, the plaintiffs seek to recover damages resulting from what they claim are violations of federal securities laws by units of Dow's management. The litigation focuses on disclosures made by the company during this class period, which supposedly misrepresented the company's financial stability and ability to maintain its acclaimed dividend payments.
The components of the class action revolve around Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, alongside Rule 10b-5, which targets fraud in the securities realm. Investors who purchased Dow securities during the affected time frame are urged to come forward by the October 28, 2025, deadline to be considered for the role of Lead Plaintiff.
Notably, Dow Inc. operates as a significant player in the materials science sector, providing solutions across various industries, including packaging, infrastructure, and consumer applications. The company traditionally emphasized its impressive dividends to attract and retain investors. Jim Fitterling, Dow's CEO, has previously touted the dividend as a cornerstone of the company's investment appeal, mentioning that a large section of their investor base highly relies on it.
However, Dow's position appears tenuous as recent market fluctuations and uncertainties linked to tariffs have begun to affect its operations seriously. Despite management claiming that the firm was well-prepared to navigate these macroeconomic challenges, numerous indicators from Dow's operational performance suggested the contrary.
Over the duration of the class period, defendants allegedly issued false and misleading information about Dow's financial health and growth potential. They purportedly downplayed the adverse effects of economic downturns and fluctuating global sales on the company's bottom line. The supposed strength of Dow's operations and its ability to sustain its dividend were presented in an overly optimistic light, which may not have reflected the actual situation.
In June 2025, BMO Capital notably downgraded Dow's stock from
Topics Other）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.